Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justine L Delgado

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|January 25, 2018
Topoisomerases as anticancer targetsJustine L Delgado, Chao-Ming Hsieh, Nei-Li Chan, et al.
European Journal of Medicinal Chemistry|April 9, 2019
Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinoloneJustine L Delgado, Sarah R C Lentz, Chaitanya A Kulkarni, et al.
Investigational New Drugs|September 11, 2018
Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activityLisa M Oppegard, Justine L Delgado, Chaitanya A Kulkarni, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|January 25, 2018
Topoisomerases as anticancer targetsJustine L Delgado, Chao-Ming Hsieh, Nei-Li Chan, et al.
European Journal of Medicinal Chemistry|April 9, 2019
Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinoloneJustine L Delgado, Sarah R C Lentz, Chaitanya A Kulkarni, et al.
Investigational New Drugs|September 11, 2018
Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activityLisa M Oppegard, Justine L Delgado, Chaitanya A Kulkarni, et al.
Pageof 1